Marisa Wexler, MS, senior science writer—

Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.

Articles by Marisa Wexler

MYELOMA

June 10, 2019 by Marisa Wexler, MS

Clinical Trial Results Suggest Isatuximab Improves Survival in People with RRMM

Isatuximab, a potential therapeutic antibody, can improve survival in relapsed/refractory multiple myeloma patients being given a standard treatment consisting of Pomalyst (pomalidomide) and…

MYELOMA

February 4, 2019 by Marisa Wexler, MS

Measuring Blood Vessel Activity May Predict Multiple Myeloma Prognosis

A panel of blood markers that identifies tumors with more active blood vessels may help stratify multiple myeloma patients according to their risk, a study found.

MYELOMA

February 1, 2019 by Marisa Wexler, MS

Single-cell Profiling in Multiple Myeloma May Improve Diagnosis, Treatment, Study Suggests

Analysis of thousands of individual cells in multiple myeloma patients allows for a much more precise diagnosis — distinguishing asymptomatic, early-stage patients from those…

Marisa Wexler, MS, senior science writer—

Articles by Marisa Wexler

Clinical Trial Results Suggest Isatuximab Improves Survival in People with RRMM

Measuring Blood Vessel Activity May Predict Multiple Myeloma Prognosis

Single-cell Profiling in Multiple Myeloma May Improve Diagnosis, Treatment, Study Suggests

Recent Posts